[at Motley Fool] – Like many of its peers, drugmaker Eli Lilly has faced some severe patent-cliff issues. Can it find the same success as Pfizer and Merck in addressing those issues and boost earnings?
Read more on this.
Pfizer Inc. (PFE), … [visit site to read more]
Similar posts:- Surface RT recovery image released to fix Windows RT 8.1 update issues – Microsoft Corporation (NYSE:MSFT) [at The Verge] – Microsoft is releasing a Surface...
- Pfizer Inc. (NYSE:PFE) – Pfizer Reports Top-Line Results From Two Lyrica® Capsules CV Phase 3b Studies [Business Wire] – Pfizer Inc. announced today top-line results...
- Market Update on Pfizer Inc. (NYSE:PFE) – Pfizer Announces Top-Line Results Of The First Two Of Five Phase 3 Clinical Trials Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis [Business Wire] – Pfizer Inc. announced today top-line results from...
